By Timmy Broderick
Oct. 23, 2024
Disability in Health Care Reporting Fellow
Science Corporation published preliminary data Tuesday from a late stage, multi-center clinical trial of a retina implant that showed promising results.
Using this prosthetic, scientists partially restored vision to people whose central visual field has holes or blurry spots. Trial participants could read text and recognize playing cards when using the implant, even though they were legally blind.
advertisement
Ophthalmologist Frank Holz, the trial’s scientific coordinator, called the results a “milestone” in treating severe vision loss caused by age-related macular degeneration. “Prior to this, there have been no real treatment options to improve vision for these patients,” said Holz, a professor at University of Bonn, Germany.
STAT+ Exclusive Story
Already have an account? Log in
Already have an account? Log in
Monthly
$39
Totals $468 per year
$39/month Get StartedTotals $468 per year
Starter
$20
for 3 months, then $399/year
$20 for 3 months Get StartedThen $399/year
Annual
$399
Save 15%
$399/year Get StartedSave 15%
11+ Users
Custom
Savings start at 25%!
Request A Quote Request A QuoteSavings start at 25%!
2-10 Users
$300
Annually per user
$300/year Get Started$300 Annually per user
View All PlansTo read the rest of this story subscribe to STAT+.
Subscribe Log In Clinical trials, disability, health tech Submit a correction requestReprintsTimmy Broderick
Disability in Health Care Reporting Fellow
Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve.